# Ernexa Therapeutics Inc.: Form 8-K, filed Jan 6, 2014

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2014-01-06
- Accepted by EDGAR: Jan 6, 2014, 17:15 ET
- Period: 2013-12-30
- Accession: 0001019687-14-000045
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968714000045/ntn_8k-123013.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968714000045/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968714000045/ntn_8k-123013.htm

Filed Jan 6, 2014.
Source: SEC EDGAR, the filing index for accession 0001019687-14-000045. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
